Severe ductopenic rejection following liver transplantation: incidence, time of onset, risk factors, treatment, and outcome.
van Hoek
B
B
Division of Hepatology, Mayo Clinic, Rochester, Minnesota 55905.
Wiesner
R H
RH
Krom
R A
RA
Ludwig
J
J
Moore
S B
SB
D000328:Adult; D001653:Bile Ducts, Intrahepatic / Q000473:pathology; D001706:Biopsy; D015331:Cohort Studies; D005260:Female; D006084:Graft Rejection; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015994:Incidence; D016031:Liver Transplantation / Q000276:immunology / Q000473:pathology; D008297:Male; D015999:Multivariate Analysis; D012307:Risk Factors; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents